
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Accenture has announced a collaboration with BioCelerate, a subsidiary of TransCelerate, to develop a platform.
Accenture has announced a collaboration with BioCelerate, a subsidiary of TransCelerate, to develop a platform allowing its member companies to aggregate and analyze preclinical and clinical information in the hopes of improving drug development efficiency.
Read the full release






